Haipeng Cheng

Haipeng Cheng is a Senior Investment Director at Sangel Capital Corp., a biomedical venture capital institution based in China.1 Here are some key details about Haipeng Cheng:

Professional Background

Haipeng Cheng has extensive experience in the life sciences and investment sectors. He currently holds the position of Senior Investment Director at Sangel Capital Corp., where he focuses on investments in the biomedical field.2

Education and Expertise

Cheng received his education from Fudan University, a prestigious institution in China.2 His areas of specialization include:

• Investments
• Life Sciences

Career Progression

Before his current role, Cheng's career path included:

• Postdoctoral Scholar
• Senior Investment Analyst
• Investment Director at Sangel Capital Corp.

Location and Network

Haipeng Cheng is based in the Greater Chicago Area.2 He has over 500 connections on LinkedIn, indicating a substantial professional network in his field.2

About Sangel Capital Corp.

Sangel Capital, where Cheng works, is one of the earliest professional biomedical venture capital institutions in China. The company:

• Focuses on life science investments
• Has a leading professional advantage in domestic biomedical investment
• Aims to identify innovative growth enterprises with significant capital value and commercial potential
• Was founded in 2009
• Has an annual revenue of $2.4 million (as of 2024)
• Employs 12 people1

Haipeng Cheng's role as Senior Investment Director at Sangel Capital Corp. places him in a key position within a company that is shaping the biomedical investment landscape in China.